Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

October 17, 2021

Profiling sirtuin activity using Copper-free click chemistry.

Bioorganic Chemistry
Alyson M CurryYana Cen
October 17, 2021

STAT3 Mediated Regulation of Glucose Metabolism in Leukemia Cells.

Gene
Burcu YucelBerna Demırcan Tan
October 16, 2021
Review

High-density lipoproteins: A promising tool against cancer.

Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids
Alice OssoliMonica Gomaraschi
October 16, 2021

Tissue schematics map the specialization of immune tissue motifs and their appropriation by tumors.

Cell Systems
Salil S BhateGarry P Nolan
October 15, 2021
Preprint
Open Access

ERα-LBD, a novel isoform of estrogen receptor alpha, promotes breast cancer proliferation and endocrine resistance

BioRxiv : the Preprint Server for Biology
Antonio StrillacciJ. Bromberg
October 15, 2021
Open Access

Comprehensive Transcriptomic Analysis of Critical RNA Regulation Associated With Metabolism and Prognosis in Clear Cell Renal Carcinoma.

Frontiers in Cell and Developmental Biology
Si LiuXin Lian
October 15, 2021

CircRNA_002178 as a ceRNA promotes the development of colorectal cancer by regulating miR-542-3p/CREB1.

American Journal of Translational Research
Ying XuJinrong Zhao
October 15, 2021
Review

Metabolic reprogramming in epithelial ovarian cancer.

American Journal of Translational Research
Chalaithorn NantasuphaNipon Chattipakorn
October 15, 2021
Review
Open Access

Metabolic Program of Regulatory B Lymphocytes and Influence in the Control of Malignant and Autoimmune Situations.

Frontiers in Immunology
Cristian IperiChristophe Jamin
October 15, 2021

Hexokinase 2-driven glycolysis in pericytes activates their contractility leading to tumor blood vessel abnormalities.

Nature Communications
Ya-Ming MengPing-Pui Wong
October 15, 2021
Open Access

3-Bromopyruvate-mediated MCT1-dependent metabolic perturbation sensitizes triple negative breast cancer cells to ionizing radiation.

Cancer & Metabolism
Irini Skaripa-KoukelliKatherine A Vallis
October 15, 2021
Open Access

AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway.

Molecular Cancer
Ram Hari PokhrelJae-Hoon Chang
October 15, 2021

Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma.

Nanoscale
Qingfu ZhuFei Liu
October 15, 2021

FV-429 enhances the efficacy of paclitaxel in NSCLC by reprogramming HIF-1α-modulated FattyAcid metabolism.

Chemico-biological Interactions
Yongjian GuoYuxin Zhou
October 15, 2021

Insulin promotes hepatocarcinoma tumorigenesis by up-regulating PKM2 expression.

Experimental Cell Research
Jingjing LiuJianlin Ren
October 15, 2021

Compound Kushen Injection intervenes metabolic reprogramming and epithelial-mesenchymal transition of HCC via regulating β-catenin/c-Myc signaling.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
Ke-Xin WangLi Gao
October 15, 2021

The unfolding role of ceramide in coordinating retinoid-based cancer therapy.

The Biochemical Journal
Botheina GhandourNadine Darwiche

Sign up to follow this feed and discover related papers.

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Anthracycline Sensitivity & Chromatin (Keystone)

Anthracyclines are used in the treatment of cancer and work by inhibiting topoisomerase II (TOP2). Recent evidence suggests that because DNA accessibility is crucial for TOP2 binding, chromatin regulatory genes should predict anthracycline response. Find the latest research on anthracycline sensitivity and chromatin regulators in this feed.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics and Chemical Tools (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Using novel chemical tools allows us to learn more about these epigenetic changes and how they impact the neoplastic process. Follow this feed to learn more about cancer epigenetics and chemical tools.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

© 2021 Meta ULC. All rights reserved
/feed-previews/cancer-metabolic-reprogramming/1f9d5e0f-b3db-479d-82d2-aa0b28f3b482